简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-02-02 14:22 Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
2021-02-01 17:01 Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
2021-02-01 16:24 Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy
2021-02-01 15:38 Takeda Completes Sale of TachoSil® to Corza Health
2021-02-01 11:28 L&T Technology Services Wins 2021 BIG Innovation Awards, USA
2021-01-29 18:14 Kioxia Accelerates Analysis of Large-Volume Data in Life Science Research Outcomes
2021-01-29 15:02 Asia Invests in Biotechnology Innovations to Boost Food Safety, Sustainability
2021-01-28 16:50 Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
2021-01-28 15:19 Takeda Achieved Carbon Neutrality in 2020
2021-01-28 09:12 Tricor Group Releases 2021 Asia Pacific Trade Report Focusing on Impact of RCEP and COVID-19 Recovery
2021-01-28 09:10 Philip Morris International Named to the 2021 Bloomberg Gender-Equality Index, Recognizing Company’s Commitment to Advancing Gender Equity
2021-01-27 17:34 Everbridge Awarded Statewide Vaccine Distribution Deployment Across West Virginia; Everbridge Software Enables Governments, Hospitals and Businesses to Coordinate Rapid Delivery and Communications of COVID-19 Vaccine
2021-01-27 17:30 New Study Concludes Xlear Kills and/or Deactivates SARS-CoV-2; Efficacy Against New Variants
2021-01-27 09:38 Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis
2021-01-26 15:08 Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients
2021-01-25 18:07 BioBytes™ – Redefining How We Care for Our Health One Byte at a Time
2021-01-25 17:35 Takeda Named Global Top Employer for Fourth Consecutive Year
2021-01-22 10:20 ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
2021-01-21 13:10 Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)
2021-01-20 15:30 ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

Business Wire Weibo

Press Releases

Latest Releases